Find Therapeutics to Participate in Upcoming Conferences
Members of management will participate in one-on-one meetings from
Members of management will present on
Find Therapeutics is dedicated to the development of next generation therapies to treat inflammatory autoimmune diseases. The company was launched in 2020 with investments from CTI Life Sciences, adMare BioInnovations and Domain Therapeutics and an exclusive license from Strasbourg University on a technology and related know-how initially developed by Dr.
View original content to download multimedia:https://www.prnewswire.com/news-releases/find-therapeutics-to-participate-in-upcoming-conferences-302157102.html
SOURCE Find Therapeutics Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026
- Mike Wood's 'One Brave Breath' Hits No. 1 Best-Seller in Multiple Amazon Categories
- New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
H.C. WainwrightSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share